Medical research
Lung drug hope for heart failure patients
An early phase trial of a drug currently used to treat lung fibrosis has shown it may also help patients who suffer from a common form of heart failure.
Aug 13, 2021
0
441
News tagged with pirfenidone
Cardiology
Scientists ID source of damaging inflammation after heart attack
Scientists have zeroed in on a culprit that spurs damaging inflammation in the heart following a heart attack. The guilty party is a type of immune cell that tries to heal the injured heart but instead triggers inflammation ...
Jun 07, 2018
0
90
Diseases, Conditions, Syndromes
Mouse studies show experimental TB treatment may do more harm than good
Johns Hopkins researchers report evidence from mouse studies that a "repurposed" drug that would be expected to improve the immune system response of tuberculosis patients may be increasing resistance to the antibiotic drugs ...
Sep 06, 2016
0
0
Diseases, Conditions, Syndromes
Two drugs offer hope for fatal lung disease
(HealthDay)—A pair of drugs offers new hope to patients with a progressive, fatal disease that robs their breath by scarring the lungs, according to clinical trial results.
May 18, 2014
0
0
Diseases, Conditions, Syndromes
Pirfenidone: Extent of added benefit assessed
Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...
Jan 03, 2012
0
0
Diseases, Conditions, Syndromes
Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis
The CAPACITY study, published Online First and in an upcoming Lancet, shows that pirfenidone reduces the rate of decline of lung function in patients with idiopathic pulmonary fibrosis—a condition of unknown cause affecting ...
May 13, 2011
0
0
